Rare
lephants
Screener
Toggle theme
DexCom, Inc.
DXCM
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2023
26.2%
26.2%
8.6%
FY2024
27.4%
27.4%
8.9%
FY2025
30.5%
30.5%
13.2%
Download CSV